That's a pretty typical ad hominem attack @Christos12
You know that I do.
I am asking genuine questions.
It's difficult to untangle APT's fixed costs.
They focus VERY heavily on users, underlying trans, NTM, etc and very little else..
So revenue doubled FY19 to FY20, but EBITDA grew by less, so at this point, your "fixed costs" are still growing as a %. I understanding investing to get USA up and running.
But difficult to model accurately..
- Forums
- ASX - By Stock
- APT
- Should I short APT now
Should I short APT now, page-32
Featured News
Add APT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online